Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab

INTRODUCTION: Erythrodermic psoriasis (EP) is a rare variant of psoriasis. Due to its rarity, evidence supporting its treatment is limited. Patients with erythrodermic psoriasis often respond less favorably to conventional treatment and have lower biologic drug survival compared with patients with p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Cheng-Ying, Tsai, Tsen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858723/
https://www.ncbi.nlm.nih.gov/pubmed/33400156
http://dx.doi.org/10.1007/s13555-020-00480-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858723/
https://www.ncbi.nlm.nih.gov/pubmed/33400156
http://dx.doi.org/10.1007/s13555-020-00480-x

Ejemplares similares